Etiology of Lymphopenia in Covid19 Infection

Dr Medhat Khafagy172 enrolled

Overview

Study of the cause of lymphopenia in Covid19 viral infection will be done in 3 cohorts. First cohort will be patients asymptomatic or with mild symptoms. Second cohort will be patients with severe illness and admitted to ICU. Third cohort will be patients critically ill and on artificial ventilation.

Each cohort will include 30 patients. Complete blood count in all patients will be done daily in all patients. Bone marrow aspiration cytology will be done in some selected patients especially those with lymphopenia less than 1000 per cubic mm. Correlation of the degree of lymphopenia with the status of the patients will be done. Also correlation will be done about the relation of recovery of lymphopenia and status of the patients.

Study Type

OBSERVATIONAL

Enrollment

172

Conditions

Lymphopenia

Interventions

Complete blood picture, bone marrow aspiration cytologyDIAGNOSTIC_TEST

none except the regular routine investigations in such cases

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Any patient admitted with the diagnosis of Covid19 viral infection Exclusion Criteria: * Any patient who died within one day of admission

Locations (1)

National Cancer Institute Cairo University

Cairo, Egypt

Outcomes

Primary Outcomes

Death or recovery

Follow up

Time frame: Up to 24 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.